intensive care unit News
-
New Support for Covid ICU Patients Now Available in the USA
USA. Ergotrics is pleased to present the world’s first inflatable prone ventilation support to improve prone ventilation in the Intensive Care Unit (ICU). Scientific studies highlight the benefits of optimized PEEP and long recruitment for ARDS patients ventilated in alternating supine/prone position, but it is one of the most challenging and ergonomically demanding position changes for ...
By Ergotrics NV
-
Microbial Outbreak Results in Deaths at Neonatal Intensive Care Unit
Cinnaminson, NJ, August 8th, 2012 The Health Minister of the Bahamas recently ordered an investigation into an outbreak of a microbial pathogen at a neonatal intensive care unit. The outbreak, caused by a type of bacteria known as Acinetobacter baumannii, is believed to have sickened eight infants and caused two of the infants to die. Outbreaks of Acinetobacter baumannii in healthcare ...
-
7th Annual Africa Hospital Expansion Summit
Africa has made considerable progress in improving their health outcomes, despite all the different challenges encountered by the countries. Indicators such as life expectancy and infant mortality improving by the day and showing the efforts of the Governments towards a healthier population. However, there is still a lot to do, since healthcare access in Africa is still constrained by criteria ...
-
Study challenges notion of `pandemic` flu
The widespread assumption that pandemic influenza is an exceptionally deadly form of seasonal, or nonpandemic, flu is hard to support, according to a new study in the May issue of the American Journal of Public Health. The study challenges common beliefs about the flu--in particular the Centers for Disease Control and Prevention (CDC) claim that 'the hallmark of pandemic influenza is excess ...
-
Yaguo Made the Second Donation
Yaguo Fight against the Epidemic!! Once again Yaguo have made a donation in order to support the frontline of the epidemic, helping with their innovating products that brings out intensive care and rehabilitation. On March 7th, YAGUO sent to Hubei a new set of respiratory devices, the number goes up to 100 devices worth around 2.2 million RMB, including bionic cough simulator (sputum removal ...
-
Study Results Are In On A Potential Non-Invasive Treatment For Rds
For little lungs everywhere, the families that love them, and the neonatologists who care for them, there’s news coming out of ONY Biotech, a family-focused neonatology pharmaceutical company. Today, ONY Biotech announced the results of a clinical trial on its aerosolized surfactant for newborns with respiratory distress syndrome (RDS), a disorder caused by lack of surfactant that can ...
By ONY Biotech
-
Palisade Bio Announces Inducement Awards Under Inducement Plan For Key New Hires
Palisade Bio (Nasdaq: PALI), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it had made equity grants to four new employees under its 2021 Inducement Plan. On May 4, 2022, the Company’s Compensation Committee granted options to four new non-executive employees covering an aggregate of 140,000 shares ...
By Palisade Bio
-
`It was a life saver`: New London developed device for feeding tube insertions is a world first
Researchers in London, Ont., are the first in the world to use a new device for feeding tube insertion that can improve patient safety and reduce the cost of health-care services. A team from Lawson Health Research Institute has partnered with CoapTech LLC, a medical device company, to study the use of the PUMA-G System. In October of last year, the medical and research teams were the first in ...
By CoapTech
-
CARMAT announces a new commercial implant of its Aeson artificial heart at University Medical Center Schleswig-Holstein in Kiel, Germany
CARMAT (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announces the third implant of its Aeson® bioprosthetic artificial heart in a commercial setting. This new commercial implant of the Aeson® device was ...
By Carmat
-
Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities
Hyperfine, Inc. (Nasdaq:HYPR), creator of Swoop®, the first FDA-cleared portable magnetic resonance imaging (MRI) system™, is proud to announce that Queen’s University and Kingston Health Sciences Centre are deploying a Swoop system as part of their health services benefitting six communities located in the James Bay and Hudson Bay Area. Until now, patients needing routine or ...
By Hyperfine
-
N8 Medical Announces First-in-Human Use of its CeraShield™ Endotracheal Tube
N8 Medical, LLC (N8 Medical) today announced its first-in-human clinical trials of its flagship CeraShield™ endotracheal tube (CeraShield™ ETT) for intensive care unit patients expected to require mechanical ventilation for more than 48 hours. N8 Medical is encouraged by preliminary study data and believes that the CeraShield™ ETT will demonstrate safety and a significant ...
-
Recent microbiome study finds that Intus Bio’s products differentiate closely related gut bacteria in premature infants
Products from Intus Biosciences demonstrated high-resolution tracking of specific bacterial strains in a recent microbiome study, the results of which are being applied to better understand how pathogens and commensals become established in premature infants in neonatal intensive care units (NICU), with the goal of improving outcomes for premature infants. Intus Biosciences is a microbiome ...
-
Fab’entech is launching an immunotherapy programme against COVID-19
Fab’entech, a Lyon-based biopharmaceutical company specialised in immunotherapies for emergency situations, is today announcing the launch of a programme to develop an immunotherapy treatment against COVID-19. The treatment will be indicated in severely ill patients requiring respiratory assistance. The clinical trials are expected to begin in humans in 2021. In order to meet the new ...
By Fab’entech
-
Showcase
ALung Announces Commercial Development of its Breakthrough Next Generation Artificial Lung
PITTSBURGH–(BUSINESS WIRE)– April 4, 2020 – ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced the recent initiation of commercial development of its next generation artificial lung, which expands the Company’s focus on highly efficient gas ...
-
M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering
Hyperfine, Inc. (Nasdaq: HYPR) (“Hyperfine”), creator of the first U.S. Food and Drug Administration (“FDA”) cleared portable magnetic resonance imaging (“MRI”)TM device, Swoop®, is proud to announce that M Health Fairview is deploying a Swoop system in the emergency room (ER), intensive care unit (ICU) and post anesthesia environments at M Health Fairview ...
By Hyperfine
-
Palisade Bio Announces $2.0 Million Registered Direct Offering
Palisade Bio, Inc. (Nasdaq: PALI) (the “Company” or “Palisade Bio”), a clinical-stage biopharmaceutical company advancing therapies for acute and chronic gastrointestinal complications, today announced that it has entered into definitive agreements with several institutional and accredited investors for the purchase and sale in a registered direct offering of 3,646,690 ...
By Palisade Bio
-
Healthcare Associated Infection Exposed in New Public Outreach Video
Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. The online video, Acinetobacter, was developed to educate the general public and healthcare providers about this potentially deadly bacterial pathogen often linked with healthcare associated infection (HAIs). Acinetobacter is a group of bacteria commonly found in soil and ...
-
tiakis receives GLP Certificate from Competent Authority
tiakis BIOTECH AG today announced that the competent Good Laboratory Practice (GLP) Monitoring Authority of the German State of Schleswig-Holstein (State Office for Agriculture, Environment and Rural Areas of the Land Schleswig-Holstein) has performed a GLP inspection resulting in the confirmation that tiakis test site is able to conduct the archiving of documents related to in-house development ...
-
Infection Control Resources to Safeguard Patients and Building Occupants from Acinetobacter and Other Pathogens
The Centers for Disease Control and Prevention describe Acinetobacter as a group of bacteria commonly found in the environment in places like soil and water. While there are many types, the most frequent cause of infections in humans is known as Acinetobacter baumannii. Those most at risk of infection according to the CDC include patients in hospitals, especially those who: · are ...
-
Midwest Hospitals on the Lookout for MDR-AB
In November of last year, a new study was published in the American Journal of Infection Control (AJIC). It indicated the common presence of Acinetobacter baumannii (MDR-AB), a dangerous multi-drug resistant bacterium, in numerous patient rooms in healthcare settings. Researchers found that MDR-AB was present in the indoor environment of 48% of the rooms of patients infected or colonized by the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you